Dusseldorf - Delayed Quote • EUR Adaptive Biotechnologies Corp (1HM.DU) Follow 2.4120 +0.0650 (+2.77%) At close: April 26 at 7:30 PM GMT+2 Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for 1HM.DU 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: 1HM.DU View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations PhaseV and Quanticate partner to help sponsors run more adaptive trials Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024 Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue The 7 Best Penny Stocks to Buy in Q2 2024 Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024 Team behind popular Falcon AI models unveils new startup with $20 million in funding aimed at helping companies tailor LLMs for business Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2023 Earnings Call Transcript Q4 2023 Adaptive Biotechnologies Corp Earnings Call Adaptive Biotechnologies Corp (ADPT) Faces Revenue Decline Amid Growth in MRD Segment Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results Here’s Why Adaptive Biotechnologies Corporation (ADPT) Declined in Q4
